MRM Health Receives FDA IND Clearance to Advance MH002 into Phase 2b Study for Ulcerative Colitis
MM Desk
19 January, 2026
MRM Health, a clinical-stage biopharmaceutical company focused on microbiome-based therapies, has received clearance from the